Leading UV technology and Infections Solutions Company Unveils Product Offerings at Upcoming Industry Conference
Surfacide, a leading UV technology and infections solutions company is proud to announce its participation and exclusive promotions at the upcoming APIC Annual Conference and Exposition in San Antonio, Texas, June 3-5. At this premiere event, the world of infection prevention and control comes together to share knowledge, innovations, and best practices.
Every year the healthcare industry looks forward to the APIC Conference for its commitment to advancing its mission by pursuing the strategic goals of patient safety, implementation science, competencies and certification, advocacy, and data standardization.
This year is no different, as the conference promises to be a strong platform for healthcare professionals, researchers, educators, and industry leaders to connect, collaborate, and shape the future of infection prevention. As the global healthcare landscape continues to evolve, the importance of infection prevention and control has never been more critical.
Surfacide will feature the following products and solutions in their booth: Helios, the industry’s-only patented, hard-surface UVC technology to use three light-emitting towers in a single cycle, and PathTrac, a clinical decision monitoring platform that proactively identifies, monitors and enhances OR disinfection. Both products maximize workflow, which is an added benefit in today’s healthcare landscape.
Surfacide invites attendees to visit their booth, #1318, for the chance to win 3 months of their UVC technology, which used in conjunction with manual cleaning reduces bacteria and viruses in patient and procedure areas, ORs, and public areas within healthcare facilities. In addition, two lucky attendees will win the chance to experience PathTrac first hand with a baseline assessment and sample kit.
“The APIC Annual Conference & Exposition allows us as an industry to discuss the latest breakthroughs, strategies, and insights that will empower us to stay at the forefront of this vital field,” said Gunner Lyslo, founder and CEO of Surfacide. “At Surfacide we’re in the business of revolutionizing healthcare facilities’ UVC programs, as well as implementing innovative programs that improve patient safety.”
